Physician profile
Michael J Bates
NPI 1932310604
$11,147.74
in general payments reported to CMS, 2019-2025
18 companies · $1,287 in 2025
The $1,287 reported for 2025 was more than what 75% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,050 · 2020: $5,382 · 2021: $5.19 · 2022: $50.67 · 2023: $189 · 2024: $184 · 2025: $1,287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,125 · Food and Beverage: $535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,125.00 |
| Food and Beverage | $535.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,299.68 | 2020 | |
| Edwards Lifesciences Corporation | $3,299.86 | 2019-2023 | Mitris Resilia Mitral Valve |
| Atricure, INC. | $1,785.89 | 2019-2025 | Synergy Ablation System |
| Baxter Healthcare | $166.78 | 2024-2025 | Floseal, Coseal, Preveleak |
| Philips North America LLC | $136.65 | 2023 | |
| Boston Scientific Corporation | $124.82 | 2019 | |
| Medtronic, INC. | $97.42 | 2025 | Corevalve Evolut R |
| Abbott Laboratories | $56.74 | 2020 | |
| Bolton Medical INC | $47.13 | 2025 | |
| Haemonetics Corporation | $33.23 | 2020-2022 | |
| W. L. Gore & Associates, INC. | $19.66 | 2024 | Gore Viabahn Vbx Balloon Expandable Endo |
| Scpharmaceuticals INC. | $15.89 | 2023 | |
| Medistim USA, INC. | $15.62 | 2024 | Miraq |
| Merck Sharp & Dohme LLC | $15.19 | 2022 | |
| Angiodynamics, INC. | $14.41 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $13.58 | 2022 | |
| Kls-Martin L.P. | $5.19 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.